Cancer-associated DNA hypermethylation of Polycomb targets requires DNMT3A dual recognition of histone H2AK119 ubiquitination and the nucleosome acidic patch
- PMID: 39196936
- PMCID: PMC11352909
- DOI: 10.1126/sciadv.adp0975
Cancer-associated DNA hypermethylation of Polycomb targets requires DNMT3A dual recognition of histone H2AK119 ubiquitination and the nucleosome acidic patch
Abstract
During tumor development, promoter CpG islands that are normally silenced by Polycomb repressive complexes (PRCs) become DNA-hypermethylated. The molecular mechanism by which de novo DNA methyltransferase(s) [DNMT(s)] catalyze CpG methylation at PRC-regulated regions remains unclear. Here, we report a cryo-electron microscopy structure of the DNMT3A long isoform (DNMT3A1) amino-terminal region in complex with a nucleosome carrying PRC1-mediated histone H2A lysine-119 monoubiquitination (H2AK119Ub). We identify regions within the DNMT3A1 amino terminus that bind H2AK119Ub and the nucleosome acidic patch. This bidentate interaction is required for effective DNMT3A1 engagement with H2AK119Ub-modified chromatin in cells. Further, aberrant redistribution of DNMT3A1 to Polycomb target genes recapitulates the cancer-associated DNA hypermethylation signature and inhibits their transcriptional activation during cell differentiation. This effect is rescued by disruption of the DNMT3A1-acidic patch interaction. Together, our analyses reveal a binding interface critical for mediating promoter CpG island DNA hypermethylation, a major molecular hallmark of cancer.
Figures
Update of
-
Cancer-associated DNA Hypermethylation of Polycomb Targets Requires DNMT3A Dual Recognition of Histone H2AK119 Ubiquitination and the Nucleosome Acidic Patch.bioRxiv [Preprint]. 2024 Mar 20:2024.03.18.585588. doi: 10.1101/2024.03.18.585588. bioRxiv. 2024. Update in: Sci Adv. 2024 Aug 30;10(35):eadp0975. doi: 10.1126/sciadv.adp0975. PMID: 38562823 Free PMC article. Updated. Preprint.
References
-
- Feinberg A. P., Cui H., Ohlsson R., DNA methylation and genomic imprinting: Insights from cancer into epigenetic mechanisms. Semin. Cancer Biol. 12, 389–398 (2002). - PubMed
MeSH terms
Substances
Grants and funding
- R44 HG011875/HG/NHGRI NIH HHS/United States
- F30 CA224971/CA/NCI NIH HHS/United States
- R35 GM138181/GM/NIGMS NIH HHS/United States
- R44 CA212733/CA/NCI NIH HHS/United States
- P01 CA098101/CA/NCI NIH HHS/United States
- P30 CA013696/CA/NCI NIH HHS/United States
- R01 CA266978/CA/NCI NIH HHS/United States
- T32 GM007739/GM/NIGMS NIH HHS/United States
- R01 AA026297/AA/NIAAA NIH HHS/United States
- R01 DE031873/DE/NIDCR NIH HHS/United States
- R44 DE029633/DE/NIDCR NIH HHS/United States
- R44 GM119893/GM/NIGMS NIH HHS/United States
- S10 OD020056/OD/NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
